Delivery Order SPE2DB22D1103-SPE2DB25FH0M9
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, valued at $3,138.37, was competitively awarded without set-aside designation and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials with a ceiling value of $1,330.18. The award, made on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 19, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injections valued at $7,156.00. The award was made by the Defense Logistics Agency under a firm fixed-price contract structure with no set-aside designation, indicating competitive award status. The order is scheduled for completion by August 20, 2025, with performance at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 5, 2025, for Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $1,001.98. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The place of performance is located at the company's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a contract ceiling value of $91,339.91. This is a firm fixed-price, non-competitive set-aside delivery order utilizing a competitive award process. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Ozempic 0.25–0.5 mg/dose pens (3 mL) valued at $7,440.06. Awarded on July 28, 2025, with a firm fixed price structure and ultimate completion date of July 29, 2025, this competitively awarded contract includes no set-aside designation. The place of performance is located at the contractor's corporate office in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) for pharmaceutical supplies on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is valued at $30,825.02 and covers the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials to support federal medical procurement needs. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $36,378.29 for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials from the Defense Medical Supply Chain on July 28, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, and was awarded on a competitive basis without set-aside designation. This delivery order represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens with a ceiling value of $3,519.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is valued at $3,759.96 and carries a firm fixed price with an ultimate completion date of August 19, 2025. The award utilized competitive procurement procedures with no set-aside designation. The place of performance is identified as the vendor's corporate office in Conshohocken, Pennsylvania. This...